Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant Interleukin enhancer-binding factor 3 (ILF3) anticorps

L’anticorps anti-Interleukin enhancer-binding factor 3 Monoclonal Lapin est utilisé pour la détection de Interleukin enhancer-binding factor 3 dans des échantillons de Humain, Souris et Rat. Il a été validé pour WB, IHC, IF et FACS.
N° du produit ABIN7828328
328,90 €
Plus frais de livraison 40,00 € et TVA
50 μL
Destination: France
Envoi sous 9 à 13 jours ouvrables

Aperçu rapide pour Recombinant Interleukin enhancer-binding factor 3 (ILF3) anticorps (ABIN7828328)

Antigène

Voir toutes Interleukin enhancer-binding factor 3 (ILF3) Anticorps
Interleukin enhancer-binding factor 3 (ILF3)

Type d'anticorp

Recombinant Antibody

Reactivité

  • 72
  • 50
  • 37
  • 13
  • 11
  • 11
  • 10
  • 5
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
Humain, Souris, Rat

Hôte

  • 67
  • 3
  • 1
Lapin

Clonalité

  • 49
  • 23
Monoclonal

Conjugué

  • 49
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
Inconjugué

Application

  • 51
  • 28
  • 20
  • 20
  • 13
  • 13
  • 12
  • 8
  • 5
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

A466
  • Fonction

    Recombinant ILF3 Monoclonal Antibody

    Purification

    Protein A purified

    Immunogène

    Recombinant human ILF3 fragment

    Isotype

    IgG, kappa
  • Indications d'application

    WB 1:2000-1:10000,IHC 1:100-1:500,IF 1:50,FCM 1:50-1:100

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS, 50 % glycerol, 0.05 % Proclin 300, 0.05 % protein protectant.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

    Date de péremption

    12 months
  • Antigène

    Interleukin enhancer-binding factor 3 (ILF3)

    Autre désignation

    ILF3

    Sujet

    ILF,MMP,Mpp,DRBP,NF-AT,MPHOSPH,TCP,ILF3,CBTF,DRBF,DRBP76,MMP4,MPHOSPH4,MPP4,NF-AT-90,NF110,NF110b,NF90,NF90a,NF90b,NFAR,NFAR-1,NFAR2,TCP110,TCP80,Double stranded RNA binding protein 76,Double-stranded RNA-binding protein 76,Interleukin enhancer binding factor 3,Interleukin enhancer-binding factor 3,M phase phosphoprotein 4,M-phase phosphoprotein 4,NF AT 90,Nuclear factor associated with dsRNA,Nuclear factor of activated T cells 90 kDa,Nuclear factor of activated T-cells 90 kDa,Translational control protein 80,Interleukin enhancer-binding factor 3 (ILF3) is a double-stranded RNA (dsRNA) binding protein that complexes with other proteins, dsRNAs, small noncoding RNAs, and mRNAs to regulate gene expression and stabilize mRNAs. This protein (NF90, ILF3) forms a heterodimer with a 45 kDa transcription factor (NF45, ILF2) required for T-cell expression of interleukin 2. This complex has been shown to affect the redistribution of nuclear mRNA to the cytoplasm. Knockdown of NF45 or NF90 protein retards cell growth, possibly by inhibition of mRNA stabilization. In contrast, an isoform (NF110) of this gene that is predominantly restricted to the nucleus has only minor effects on cell growth when its levels are reduced. Alternative splicing results in multiple transcript variants encoding distinct isoforms. ILF3 exists main two isoforms NFAR-1 (90 kDa) and -2 (110 kDa). Upon viral infection, ILF3 accumulates in the cytoplasm and participates in the innate antiviral response. Cat.No. Product Name Clone No. IF:{{item.impact}} Journal:{{item.journal}} ({{item.year}}) DOI:{{item.doi}} Reactivity:{{item.species}} Sample Type:{{item.sample_type}} Previous {{ page }} Next Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}} Previous {{ page }} Next [

    Poids moléculaire

    Calculated MW: 95 kDa

    Observed MW: 90,110 kDa The actual band is not consistent with the expectation.

    UniProt

    Q12906

    Pathways

    M Phase
Vous êtes ici:
Chat with us!